GlyT1 inhibitors (Helicon Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGlyT1 inhibitors (Helicon Therapeutics)
Drug Alias Nameglycine transporter-1 inhibitors (Helicon Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycine transporter 1 inhibitors
TargetsGlycine transporter 1
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDart Neuroscience Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDart Neuroscience Llc
Active IndicationsN/A
Inactive IndicationsCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A